Universe Pharmaceuticals Inc.

UPC

$4.08

-5.77%

2026-09-04 09:53:00 EDT-$0.25

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, ...

Key Metrics of UPC

Snapshot

Latest / TTM · 6 periods

Market Cap

$2.58M

ROCE

-3.6%

EV / EBITDA

11.82x

+1.6% YoY

FCF Yield

-480.8%

+36482.9% YoY

Cash Conversion Cycle

428.2d

Current Ratio

4.05

Quick take

TTM —

Positive CCC

Key Metrics

Latest / TTM · 6 periods

Valuation trend

Valuation trend table

Metric	2021	2022	2023	2024	2025	TTM
Market CapTotal market value of all shares outstanding.	$46.88M	$12.05M	$3.38M	$889,672.8	$14,607.6	$2.58M
Enterprise ValueCompany value including debt and cash adjustments.	$43.14M	$10.27M	$3.57M	$-20.61M	$-24.32M	$-15.43M
EV / SalesHow many dollars investors pay per dollar of sales.	0.90x	0.26x	0.11x	-0.90x	-1.36x	-0.87x
EV / EBITDAValuation multiple versus operating earnings before non-cash charges.	3.04x	-1.61x	-1.12x	2.80x	8.32x	11.82x
Net Debt / EBITDALeverage ratio using net debt divided by EBITDA.	-0.26	0.28	-0.06	2.92	8.33	13.80

Returns + ROCE gauge

ROCE latest

-3.6%

Prev year -5.2%

Returns + ROCE gauge table

Metric	2021	2022	2023	2024	2025	TTM
ROEProfit generated from shareholders' equity.	19.2%	-18.8%	-15.6%	-19.2%	-6.5%	-3.5%
ROAProfit generated from total assets.	16.1%	-14.7%	-11.6%	-12.8%	-5.3%	-2.7%
ROICReturn generated on invested operating capital.	20.8%	-18.0%	-15.2%	-18.0%	-6.2%	-3.1%
ROCEOperating return on long-term capital used.	23.1%	-15.1%	-8.9%	-16.8%	-5.2%	-3.6%
Earnings YieldEarnings as a percentage of market value.	24.1%	-72.5%	-182.5%	-981.0%	-25138.0%	-84.5%

Cash flow quality

Cash flow quality table

Metric	2021	2022	2023	2024	2025	TTM
FCFFCash flow available to all capital providers.	$-15.50M	$-1.23M	$1.32M	$-9.45M	$-5.09M	$-12.22M
FCFECash flow available to equity holders after debt flows.	$-14.96M	$1.91M	$-314,733	$-798,148	$-10.59M	$-19.27M
FCF YieldFree cash flow divided by market capitalization.	-33.2%	-11.7%	31.9%	-1109.4%	-36963.7%	-480.8%
Income QualityHow well accounting earnings are backed by cash flow.	-0.18	0.17	-0.17	1.09	1.38	6.13
Capex / OCFShare of operating cash flow spent on capital expenditures.	-658.2%	-7.1%	3.9%	-3.8%	-6.9%	-4.0%

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	TTM
DSOAverage days to collect cash from customers.	120.3d	138.1d	121.2d	283.4d	269.5d	420.9d
DIOAverage days inventory stays before being sold.	39.7d	44.1d	55.5d	37.4d	69.3d	127.7d
DPOAverage days the company takes to pay suppliers.	85.6d	61.5d	76.1d	105.8d	52.7d	120.4d
Operating CycleTime from buying inventory to collecting receivables.	159.9d	182.2d	176.7d	320.8d	338.8d	548.6d
Cash Conversion CycleNet days cash is tied in operations.	74.4d	120.7d	100.6d	215.0d	286.0d	428.2d

Snapshot

Latest / TTM: —

Market Cap

$2.58M

ROE

-3.5%

FCF Yield

-480.8%

Current Ratio

4.05

Upstream

TCM Raw Herb Suppliers (various unlisted Jiangxi/PRC-based trading companies and herb growers)Pharmaceutical Trading Companies (PRC-based, unnamed in filings)Herb Farmers and Agricultural Cooperatives (Jiangxi Province and surrounding regions)Packaging & Labeling Material Suppliers (PRC-based, unnamed)Kitanihon Pharmaceutical Co., Ltd.

Downstream

Pharmaceutical Companies (PRC provincial-level distributors)Hospitals (primarily in Jiangxi, Jiangsu, Guangdong provinces)Clinics (primary care and TCM-focused clinics across 30 provinces)Drugstore Chains (retail pharmacy chains in 30 provinces)Kitanihon Pharmaceutical Co., Ltd.

Proxies

China Traditional Chinese Medicine Holdings Co. LimitedHKEx:0570 Beijing Tong Ren Tang Chinese Medicine Co., Ltd.HKEx:3613Yunnan Baiyao Group Co., Ltd.SZSE:000538

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Universe Pharmaceuticals Inc.

Key Metrics of UPC

Key Metrics

Valuation trend

Returns + ROCE gauge

Cash flow quality

Operating efficiency

Snapshot

Supply Chain of UPC

Upstream

Downstream

Proxies

Key Metrics of UPC

Key Metrics

Valuation trend

Returns + ROCE gauge

Cash flow quality

Operating efficiency

Snapshot

Supply Chain of UPC

Upstream

Downstream

Proxies